Patients who are part of the OneSource program and rely on public transit can now take a reimbursed ridesharing/taxi service to and from the infusion clinic where they receive their eculizumab treatments.
Alexion Canada (the manufacturer of eculizumab) hopes this service will help alleviate any concerns patients may have regarding taking public transit when travelling to and from infusion clinics during this unprecedented time.
Details about this program:
The OneSource program is now offering travel assistance should a patient indicate that they regularly take public transit to and from their infusion clinic appointments.
Patients will choose and book their own car service to and from their appointments.
Alexion recommends using Uber, Talixo or Lyft as these companies have implemented strict policies around car cleaning in light of COVID-19.
Lyft (Only available to residents in ON and BC)
Website: https://www.lyft.com/rider
How to use this service: https://help.lyft.com/hc/en-ca/articles/115013079988-How-to-request-a-ride
Uber
Website: https://www.uber.com/ca/en/
How to use this service: https://www.uber.com/ca/en/ride/how-it-works/
Talixo
Website: https://talixo.com/
How to use the service: https://talixo.com/how-it-works/
After the infusion appointment, the patient must submit their receipts to the program via email and OneSource will process reimbursement accordingly.
Patients can send their receipts to: ospinfo@innomar-strategies.com
If you have any questions about this new offering, contact your OneSource nurse case manager for further details.
